111 (NASDAQ:YI – Get Free Report) and MSP Recovery (NASDAQ:MSPR – Get Free Report) are both small-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their profitability, risk, analyst recommendations, earnings, valuation, dividends and institutional ownership.
Institutional & Insider Ownership
21.3% of 111 shares are held by institutional investors. Comparatively, 3.8% of MSP Recovery shares are held by institutional investors. 43.9% of 111 shares are held by company insiders. Comparatively, 50.5% of MSP Recovery shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.
Profitability
This table compares 111 and MSP Recovery’s net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| 111 | -0.76% | N/A | -3.80% |
| MSP Recovery | -7,328.48% | -326.80% | -81.27% |
Analyst Recommendations
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| 111 | 1 | 0 | 0 | 0 | 1.00 |
| MSP Recovery | 1 | 0 | 0 | 0 | 1.00 |
Volatility and Risk
111 has a beta of 0.6, suggesting that its share price is 40% less volatile than the S&P 500. Comparatively, MSP Recovery has a beta of -2.38, suggesting that its share price is 338% less volatile than the S&P 500.
Valuation & Earnings
This table compares 111 and MSP Recovery”s revenue, earnings per share (EPS) and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| 111 | $1.80 billion | 0.02 | -$9.65 million | ($1.40) | -3.26 |
| MSP Recovery | $9.81 million | 0.03 | -$360.50 million | ($572.83) | 0.00 |
111 has higher revenue and earnings than MSP Recovery. 111 is trading at a lower price-to-earnings ratio than MSP Recovery, indicating that it is currently the more affordable of the two stocks.
Summary
111 beats MSP Recovery on 8 of the 11 factors compared between the two stocks.
About 111
111, Inc. engages in the provision of pharmaceutical products and medical services through online retail pharmacy and indirectly through offline pharmacy network. It operates through the B2C and B2B segments. The B2C segment engages in the sale of pharmaceutical and other health and wellness products directly to consumers through 1 Drugstore and its offline pharmacies. The B2B segment includes the sale of pharmaceutical products to pharmacy customers through 1 Drug Mall. The company was founded by Gang Yu and Jun Ling Liu in May 2013 and is headquartered in Shanghai, China.
About MSP Recovery
MSP Recovery, Inc. engages in the development of healthcare recoveries and data analytics software. It also focuses on the identification and recoveries of improper payments made by Medicare, Medicaid, and commercial insurance spaces using data and analytics. The company was founded by John H. Ruiz, Frank C. Quesada, and Diana Diaz on July 8, 2014 and is headquartered in Miami, FL.
Receive News & Ratings for 111 Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for 111 and related companies with MarketBeat.com's FREE daily email newsletter.
